Susquehanna Fundamental Investments’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-109,827
| Closed | -$2.61M | – | 1007 |
|
|
2024
Q1 | $2.61M | Buy |
+109,827
| New | +$2.61M | 0.12% | 200 |
|
|
2023
Q2 | – | Sell |
-26,678
| Closed | -$563K | – | 848 |
|
|
2023
Q1 | $563K | Sell |
26,678
-34,836
| -57% | -$736K | 0.01% | 648 |
|
|
2022
Q4 | $1.57M | Buy |
61,514
+16,270
| +36% | +$414K | 0.03% | 550 |
|
|
2022
Q3 | $1.09M | Buy |
+45,244
| New | +$1.09M | 0.02% | 783 |
|
|
2022
Q1 | $463K | Buy |
+26,666
| New | +$463K | 0.01% | 1108 |
|